California Law Student’s London Death Examined at Inquest After Tirzepatide Use

The death of a 19-year-old California law student while studying in London has been examined at an inquest, where officials heard that her prescribed use of the weight management medication tirzepatide may have contributed to a chain of medical events that ended in a fatal cardiac arrhythmia.

Josephine Nasr, a second-year law student from California, was found dead inside her accommodation at the University of East London on September 23, 2025. Details surrounding her death were presented at an East London Coroner’s Court hearing, according to reports by the New York Post and the Daily Mail.

The case has drawn attention because of the circumstances surrounding Nasr’s sudden illness and the potential interaction between medication-related side effects and an underlying heart condition.

What happened to Josephine Nasr?

According to evidence reported from the inquest, Nasr had been prescribed tirzepatide by her doctor in California. Tirzepatide is a medication used under brand names including Mounjaro and Zepbound. It is prescribed for type 2 diabetes in certain circumstances and for weight management, with Zepbound also approved for specific patients with obstructive sleep apnea.

Nasr reportedly had a body mass index that placed her in the overweight category rather than the obese category.

About a week before her death, she had returned to London after visiting her family home in California. On the evening of September 23, she reportedly told family members that she was experiencing nausea and vomiting.

Her sister, Anastasia Nasr, became concerned that the continued vomiting could leave Josephine dehydrated. She contacted a private healthcare provider with the intention of arranging intravenous fluids.

When Josephine stopped responding to messages and calls, her sister became increasingly worried. A welfare check was subsequently requested at the university.

University security staff and a nurse entered the student’s accommodation and found her on the bathroom floor. A London Ambulance Service paramedic later pronounced her dead at the scene.

An empty vial of tirzepatide was reportedly discovered in the room.

Inquest examines possible medical chain

The inquest considered several factors in determining how a seemingly sudden death occurred in a young woman.

A post-mortem examination conducted by pathologist Alan Bates identified a congenital heart condition known as myocardial bridging. The condition involves a portion of a coronary artery passing through the heart muscle rather than lying entirely on its surface.

The significance of the condition in Nasr’s case was considered alongside the effects of her illness and medication use.

According to evidence presented at the hearing, vomiting associated with tirzepatide may have contributed to hypoglycemia and an electrolyte imbalance. Changes in electrolyte levels can affect the heart’s electrical activity and, in certain circumstances, increase the risk of an abnormal heart rhythm.

The inquest heard that these factors may have placed additional stress on Nasr's underlying heart condition.

The coroner ultimately concluded that the cause of death was cardiac arrhythmia. The conclusion reportedly linked the arrhythmia to myocardial bridging and an electrolyte imbalance associated with hypoglycemia, which was attributed to the prescribed tirzepatide.

Pathologist Alan Bates described Nasr as an otherwise healthy young woman.

Tirzepatide and known side effects

Tirzepatide belongs to a class of medicines known as dual GIP and GLP-1 receptor agonists. These medications work on hormone pathways involved in blood sugar regulation and appetite.

The drugs have become increasingly popular because of their effectiveness in helping some patients manage blood glucose and lose weight. However, like all medicines, they can cause side effects.

The Mayo Clinic lists nausea and vomiting among possible side effects associated with tirzepatide.

For many people, these symptoms may be temporary and manageable. However, persistent vomiting can potentially result in dehydration and changes in the body's electrolyte levels. Electrolytes such as potassium and sodium play important roles in normal nerve and heart function.

The circumstances described at Nasr's inquest illustrate why severe or persistent symptoms should not automatically be dismissed as routine medication side effects.

At the same time, the medical details of one individual's death should not be interpreted as evidence that tirzepatide poses the same risk to every person who takes it. Nasr was also found to have an underlying congenital heart condition, which was an important part of the coroner's conclusion.

A family remembers a young woman

Beyond the medical evidence, Nasr's family used the inquest to remember her as more than the circumstances surrounding her death.

Her father, George Nasr, described his daughter as being "full of joy" and said she regularly put other people before herself.

Her mother, Lorin Mansour, also spoke about Josephine's commitment to helping others and connected that generosity to the family's Coptic Christian faith.

The family said she loved traveling and spending time near the ocean.

Nasr had been studying law in London as part of her university experience. Her death therefore came not only as a devastating loss to her family but also as the sudden end of the life of a young student living far from home.

What the case means for people taking weight loss medications

The growing use of medications such as tirzepatide has led to increasing public discussion about their benefits and potential risks.

Patients taking these medicines should follow their prescriber's instructions and seek medical advice if they experience severe, persistent or unusual symptoms. Vomiting that continues for an extended period can be particularly concerning because of the possibility of dehydration and metabolic changes.

People with known medical conditions should also discuss their complete medical history with their healthcare professional before beginning or continuing prescription medication.

Nasr's case is particularly complex because the inquest considered both an inherited or congenital cardiac abnormality and the physiological effects associated with vomiting, hypoglycemia and electrolyte imbalance.

It is therefore important to distinguish between the coroner's findings in this individual case and broader claims about the safety or effectiveness of tirzepatide.

The case also highlights the importance of seeking appropriate medical attention when someone taking a prescription medication develops significant symptoms, particularly when they become unresponsive or appear seriously unwell.

Josephine Nasr's death remains a deeply personal tragedy for her family and those who knew her. The inquest provided an account of the medical factors considered to have contributed to her death, while her family has emphasized the personality and values of the young woman they lost.

Sources

The New York Post, published August 9, 2026, and the Daily Mail, as well as medication information from the Mayo Clinic concerning tirzepatide and its potential side effects.

Disclaimer

This article is provided for general informational purposes and is not medical advice. It should not be used to diagnose a medical condition, determine whether a medication is appropriate, or replace advice from a qualified healthcare professional. Medication risks can vary significantly between individuals. Anyone experiencing severe or persistent vomiting, dehydration, fainting, chest pain, abnormal heartbeat, confusion or other concerning symptoms should seek urgent medical attention. The medical circumstances described in this article concern one individual case and should not be interpreted as proof that tirzepatide will cause the same outcome in other patients.